XML 35 R27.htm IDEA: XBRL DOCUMENT v3.24.2.u1
Revenue and Accounts Receivable Credit Concentration (Tables)
6 Months Ended
Jun. 30, 2024
Revenue from Contract with Customer [Abstract]  
Summary of Revenue

Revenues consisted of the following (in thousands):

 

 

Three Months Ended June 30,

 

 

Six Months Ended June 30,

 

 

 

2024

 

 

2023

 

 

2024

 

 

2023

 

Diagnostic Tests

 

$

16,539

 

 

$

11,449

 

 

$

30,335

 

 

$

20,094

 

Biopharmaceutical Services and other

 

 

1,386

 

 

 

423

 

 

 

2,408

 

 

 

834

 

Total revenue

 

$

17,925

 

 

$

11,872

 

 

$

32,743

 

 

$

20,928

 

Summary of Revenue and Accounts Receivable by Third-party Payors and Other Customers

The Company’s customers in excess of 10% of total revenue and their related revenue as a percentage of total revenue were as follows:

 

 

Three Months Ended June 30,

 

 

Six Months Ended June 30,

 

 

 

2024

 

 

2023

 

 

2024

 

 

2023

 

United Healthcare

 

 

13

%

 

 

11

%

 

 

12

%

 

 

11

%

 

The Company’s third-party payors and other customers in excess of 10% of accounts receivable, and their related accounts receivable as a percentage of total accounts receivable were as follows:

 

 

As of

 

 

 

June 30, 2024

 

 

December 31, 2023

 

Medicare

 

 

21

%

 

 

21

%